Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia

Gut

Volumn 66, Issue 8, 2017, Pages 1441-1448

  Wong, Sunny H ^a,b   Kwong, Thomas N Y ^a,b   Chow, Tai Cheong ^a,b   Luk, Arthur K C ^a,b   Dai, Rudin Z W ^a,b   Nakatsu, Geicho ^a,b   Lam, Thomas Y T ^a,b   Zhang, Lin ^a,b   Wu, Justin C Y ^a,b   Chan, Francis K L ^a,b   Ng, Simon S M ^a,b   Wong, Martin C S ^a,b   Ng, Siew C ^a,b   Wu, William K K ^a,b   Yu, Jun ^a,b   Sung, Joseph J Y ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Prince of Wales Hospital   (Hong Kong)

Author keywords

COLONIC MICROFLORA; COLORECTAL ADENOMAS; COLORECTAL CANCER; COLORECTAL CANCER SCREENING

Indexed keywords

BIOLOGICAL MARKER; BACTERIAL DNA; TUMOR MARKER;

ADULT; ARTICLE; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL TUMOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FECAL IMMUNOCHEMICAL TEST; FECES MICROFLORA; FEMALE; FUSOBACTERIUM; FUSOBACTERIUM NUCLEATUM; HUMAN; MAJOR CLINICAL STUDY; MALE; PARVIMONAS MICRA; PEPTOSTREPTOCOCCUS ANAEROBIUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR DIAGNOSIS; ADENOCARCINOMA; ADENOMA; AREA UNDER THE CURVE; FECES; MICROBIOLOGY; MIDDLE AGED; OCCULT BLOOD; PEPTOSTREPTOCOCCUS; RECEIVER OPERATING CHARACTERISTIC; VALIDATION STUDY;

ADENOCARCINOMA; ADENOMA; AREA UNDER CURVE; BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; DNA, BACTERIAL; FECES; FEMALE; FUSOBACTERIUM NUCLEATUM; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; PEPTOSTREPTOCOCCUS; ROC CURVE;

EID: 84994759860     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-312766     Document Type: Article

References (31)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
2. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012;366:2345-57.
3. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: A multicentre randomised controlled trial. Lancet 2010;375:1624-33.
4. Sung JJ, Ng SC, Chan FK, et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut 2015;64:121-32.
5. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol 2009;104:739-50.
6. Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-Analysis. Ann Intern Med 2014;160:171.
7. Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 2009;150:162-9.
8. Haug U, Hundt S, Brenner H. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests. Am J Gastroenterol 2010;105:682-90.
9. Yu J, Feng Q, Wong SH, et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut Published Online First: 25 Sep 2015. doi:10.1136/gutjnl-2015-309800
10. Nakatsu G, Li X, Zhou H, et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat Commun 2015;6:8727.
11. Zeller G, Tap J, Voigt AY, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol 2014;10:766.
12. Feng Q, Liang S, Jia H, et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun 2015;6:6528.
13. Zackular JP, Rogers MA, Ruffin MTt, et al. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res (Phila) 2014;7:1112-21.
14. Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013;14:207-15.
15. Rubinstein MR, Wang X, Liu W, et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microb 2013;14:195-206.
16. Abed J, Emgard JE, Zamir G, et al. Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microbe 2016;20:215-25.
17. Wu CW, Ng SC, Dong Y, et al. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma. Clin Cancer Res 2014;20:2994-3002.
18. Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Gastrointest Endosc 2006;63:S16-28.
19. Castellarin M, Warren RL, Freeman JD, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012;22:299-306.
20. Fraser CG, Allison JE, Young GP, et al. A standard for Faecal Immunochemical TesTs for haemoglobin evaluation reporting (FITTER). Ann Clin Biochem 2014;51:301-2.
21. Huang Y, Pepe MS, Feng Z. Logistic regression analysis with standardized markers. Ann Appl Stat 2013;7:1640-62.
22. Mima K, Nishihara R, Qian ZR, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut Published Online First: 26 Aug 2015. doi:10.1136/gutjnl-2015-310101
23. Etzioni R, Kooperberg C, Pepe M, et al. Combining biomarkers to detect disease with application to prostate cancer. Biostatistics 2003;4:523-38.
24. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 2014;371:187-8.
25. McCoy AN, Araújo-Pérez F, Azcárate-Peril A, et al. Fusobacterium is associated with colorectal adenomas. PLoS ONE 2013;8:e53653.
26. Baxter NT, Ruffin MTt, Rogers MA, et al. Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions. Genome Med 2016;8:37.
27. Sung JJ, Lau JY, Goh KL, et al. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 2005;6:871-6.
28. Ng SC, Wong SH. Colorectal cancer screening in Asia. Br Med Bull 2013;105:29-42.
29. Sung JJ, Chan FK, Leung WK, et al. Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. Gastroenterology 2003;124:608-14.
30. Wong MC, Ching JY, Chan VC, et al. The comparative cost-effectiveness of colorectal cancer screening using faecal immunochemical test vs. colonoscopy. Sci Rep 2015;5:13568.
31. Ladabaum U, Mannalithara A. Comparative effectiveness and cost effectiveness of a multitarget stool DNA test to screen for colorectal neoplasia. Gastroenterology 2016;151:427-39.e6.